In China,the medical guidelines recommend performing noninvasive prenatal testing(NIPT)with caution for pregnant women aged 35 years or older.However,the Mother and Child Health Care Law suggests that all primiparous ...In China,the medical guidelines recommend performing noninvasive prenatal testing(NIPT)with caution for pregnant women aged 35 years or older.However,the Mother and Child Health Care Law suggests that all primiparous women whose age is older than 35 years undergo prenatal diagnosis.These two inconsistent suggestions/recommendations have made obstetricians confused about whether to offer NIPT to these older pregnant women.To face this issue and find out the solution we performed a retrospective study of 189,809 NIPT samples collected from 28 provincial-leveled administrative units in China.Of 1,564 women with high-risk pregnancies who underwent NIPT,459(29.3%)did not participate in follow-up.The compound sensitivity and specificity of NIPT for trisomies 21,18 and 13 detection was 99.1%(95%CI,98.0%–99.6%)and 99.9%(95%CI,98.8%–99.9%),respectively.In secundiparous women,NIPT showed high sensitivity and specificity similar to that in primiparous women.The observed risk for trisomies 21 and 18 significantly increased when the maternal age was 39 and older.After the publication of the current NIPT policy,the follow-up rate at our center was 97.9%;however,a large number of women are not in maternal and infant care networks nationwide,and that makes the follow-up rate outside our center relatively low.Our study shows that to balance the prevention of major aneuploidies and the limited resources for prenatal diagnosis,the cut-off age of 35 for invasive prenatal diagnosis might be unnecessary.Although the NIPT guidelines are well written,how to practice it effectively,especially in less industrialized areas,is worth discussing.展开更多
目的：总结妊娠中期羊水20-三体假性嵌合体的产前诊断及遗传咨询的特点。方法对1例妊娠中期羊水20-三体假性嵌合体病例及相关文献进行分析。结果孕妇31岁，妊1产0，妊娠16周时，母体血清学筛查提示胎儿21-三体风险值为1/200，于2012年9...目的：总结妊娠中期羊水20-三体假性嵌合体的产前诊断及遗传咨询的特点。方法对1例妊娠中期羊水20-三体假性嵌合体病例及相关文献进行分析。结果孕妇31岁，妊1产0，妊娠16周时，母体血清学筛查提示胎儿21-三体风险值为1/200，于2012年9月妊娠18周行羊膜腔穿刺术。采用GLP13/GLP21/CSP18/CSPX/CSPY探针的羊水间期细胞荧光原位杂交（fluorescence in situ hybridization，FISH）分析未见异常信号，羊水细胞培养和染色体核型分析结果为47,XY,＋20[7]/46,XY[9]，三体细胞系占7/16。进一步行脐静脉穿刺，脐血染色体核型为46,XY。对羊水间期细胞行D20Z1（20p11.1-q11.1）和D20S1157/20QTEL14（20per/qter）探针的 FISH 分析，各个探针在所有细胞中均只出现2个信号。妊娠24周行系统胎儿超声检查未见异常。综合分析上述情况，考虑该20-三体嵌合体为假性嵌合体。孕妇及其家属决定继续妊娠，至妊娠39周经阴道分娩一男性活婴，儿科体格检查未见异常。该婴儿随访至生后7个月，外观及发育未见异常。取该婴儿外周血查染色体核型为46,XY，同时取其口腔颊黏膜脱落细胞行D20Z1、D20S1157/20QTEL14探针的间期FISH分析，在所有细胞中均只出现2个信号，进一步证实产前诊断的结果。结论对羊水20-三体嵌合体需进行充分评估，对孕妇及配偶进行充分的产前咨询。间期FISH对评估嵌合体具有重要价值。产后应对多种组织行染色体核型分析或间期FISH的复核。展开更多
AIM: To investigate the relation of the response to Helicobacter pylori eradication therapy to the depth of tumor invasion and chromosome abnormalities in patients with mucosaassociated lymphoid tissue (MALT) lymphoma...AIM: To investigate the relation of the response to Helicobacter pylori eradication therapy to the depth of tumor invasion and chromosome abnormalities in patients with mucosaassociated lymphoid tissue (MALT) lymphoma and to determine the clinical value of aneuploidy.METHODS: We studied 13 patients with localized gastric MALT lymphoma of stage E1. Before eradication therapy,the depth of tumor invasion was assessed by endoscopic ultrasonography in 8 patients and by endoscopic examination and gastrointestinal series in the remaining patients. To detect chromosomal abnormalities, paraffin-embedded tissue sections of diagnostic biopsy specimens underwent tissuefluorescence in situ hybridization (FISH), using chromosomespecific α-satellite DNA probes for chromosomes 3,7,12,and 18 and YAC clones for t(11;18)(q21;q21).RESULTS: Seven of the 13 patients had complete regression(CR) in response to H pylori eradication therapy. No patient with CR had submucosal tumor invasion. Trisomy 18 was seen in 1 patient with CR, and both trisomies 12 and 18 were present in another patient with CR. All patients with no response or progressive disease had deep submucosal tumor invasion and showed t(11;18)(q21;q21) or trisomy 3. Trisomy 7 was not detected in this series of patients.CONCLUSION: The depth of tumor invasion is an accurate predictor of the response of stage E1 MALT lymphoma to H pylori eradication therapy and is closely associated with the presence of chromosomal abnormalities. Trisomy 3 may predict the aggressive development of MALT lymphoma.展开更多
目的:探讨分析无创产前筛查(noninvasive prenatal screening,NIPS)技术在罕见常染色体三体(rare autosomal trisomies,RAT)及染色体拷贝数变异(copy number variation,CNV)筛查中的临床意义。方法:回顾性分析于2017年3月—2023年7月因N...目的:探讨分析无创产前筛查(noninvasive prenatal screening,NIPS)技术在罕见常染色体三体(rare autosomal trisomies,RAT)及染色体拷贝数变异(copy number variation,CNV)筛查中的临床意义。方法:回顾性分析于2017年3月—2023年7月因NIPS提示RAT和(或)CNV高风险在泉州市妇幼保健院·儿童医院产前诊断中心行羊水染色体核型分析及单核苷酸多态性微阵列(single nucleotide polymorphism array,SNParray)检测的108例患者情况。结果:83例NIPS提示RAT高风险者中产前诊断结果异常共15例,阳性预测值为18.07%,分别为1例致病性拷贝数变异(pathogenic copy number variants,pCNV)、9例临床意义不明确(variants of uncertain significance,VOUS)、4例杂合性丢失(loss of heterozygosity,LOH)及1例VOUS+LOH。25例NIPS提示CNV高风险者中产前诊断结果异常共16例,阳性预测值为64.00%,分别为11例pCNV、1例可能致病性拷贝数变异(likely pathogenic copy number variants,lpCNV)及4例VOUS。结论:NIPS技术对于RAT高风险阳性预测值不高,但提示不良妊娠结局风险增加;对于CNV高风险筛查有一定的应用价值。当NIPS提示RAT和染色体CNV高风险,应结合产前诊断结果及超声随访对胎儿预后进行评估,并加强妊娠期监测和管理。展开更多
基金supported by grants from the National Key Technology R&D Program (2015BAI13B06).
文摘In China,the medical guidelines recommend performing noninvasive prenatal testing(NIPT)with caution for pregnant women aged 35 years or older.However,the Mother and Child Health Care Law suggests that all primiparous women whose age is older than 35 years undergo prenatal diagnosis.These two inconsistent suggestions/recommendations have made obstetricians confused about whether to offer NIPT to these older pregnant women.To face this issue and find out the solution we performed a retrospective study of 189,809 NIPT samples collected from 28 provincial-leveled administrative units in China.Of 1,564 women with high-risk pregnancies who underwent NIPT,459(29.3%)did not participate in follow-up.The compound sensitivity and specificity of NIPT for trisomies 21,18 and 13 detection was 99.1%(95%CI,98.0%–99.6%)and 99.9%(95%CI,98.8%–99.9%),respectively.In secundiparous women,NIPT showed high sensitivity and specificity similar to that in primiparous women.The observed risk for trisomies 21 and 18 significantly increased when the maternal age was 39 and older.After the publication of the current NIPT policy,the follow-up rate at our center was 97.9%;however,a large number of women are not in maternal and infant care networks nationwide,and that makes the follow-up rate outside our center relatively low.Our study shows that to balance the prevention of major aneuploidies and the limited resources for prenatal diagnosis,the cut-off age of 35 for invasive prenatal diagnosis might be unnecessary.Although the NIPT guidelines are well written,how to practice it effectively,especially in less industrialized areas,is worth discussing.
文摘目的：总结妊娠中期羊水20-三体假性嵌合体的产前诊断及遗传咨询的特点。方法对1例妊娠中期羊水20-三体假性嵌合体病例及相关文献进行分析。结果孕妇31岁，妊1产0，妊娠16周时，母体血清学筛查提示胎儿21-三体风险值为1/200，于2012年9月妊娠18周行羊膜腔穿刺术。采用GLP13/GLP21/CSP18/CSPX/CSPY探针的羊水间期细胞荧光原位杂交（fluorescence in situ hybridization，FISH）分析未见异常信号，羊水细胞培养和染色体核型分析结果为47,XY,＋20[7]/46,XY[9]，三体细胞系占7/16。进一步行脐静脉穿刺，脐血染色体核型为46,XY。对羊水间期细胞行D20Z1（20p11.1-q11.1）和D20S1157/20QTEL14（20per/qter）探针的 FISH 分析，各个探针在所有细胞中均只出现2个信号。妊娠24周行系统胎儿超声检查未见异常。综合分析上述情况，考虑该20-三体嵌合体为假性嵌合体。孕妇及其家属决定继续妊娠，至妊娠39周经阴道分娩一男性活婴，儿科体格检查未见异常。该婴儿随访至生后7个月，外观及发育未见异常。取该婴儿外周血查染色体核型为46,XY，同时取其口腔颊黏膜脱落细胞行D20Z1、D20S1157/20QTEL14探针的间期FISH分析，在所有细胞中均只出现2个信号，进一步证实产前诊断的结果。结论对羊水20-三体嵌合体需进行充分评估，对孕妇及配偶进行充分的产前咨询。间期FISH对评估嵌合体具有重要价值。产后应对多种组织行染色体核型分析或间期FISH的复核。
文摘AIM: To investigate the relation of the response to Helicobacter pylori eradication therapy to the depth of tumor invasion and chromosome abnormalities in patients with mucosaassociated lymphoid tissue (MALT) lymphoma and to determine the clinical value of aneuploidy.METHODS: We studied 13 patients with localized gastric MALT lymphoma of stage E1. Before eradication therapy,the depth of tumor invasion was assessed by endoscopic ultrasonography in 8 patients and by endoscopic examination and gastrointestinal series in the remaining patients. To detect chromosomal abnormalities, paraffin-embedded tissue sections of diagnostic biopsy specimens underwent tissuefluorescence in situ hybridization (FISH), using chromosomespecific α-satellite DNA probes for chromosomes 3,7,12,and 18 and YAC clones for t(11;18)(q21;q21).RESULTS: Seven of the 13 patients had complete regression(CR) in response to H pylori eradication therapy. No patient with CR had submucosal tumor invasion. Trisomy 18 was seen in 1 patient with CR, and both trisomies 12 and 18 were present in another patient with CR. All patients with no response or progressive disease had deep submucosal tumor invasion and showed t(11;18)(q21;q21) or trisomy 3. Trisomy 7 was not detected in this series of patients.CONCLUSION: The depth of tumor invasion is an accurate predictor of the response of stage E1 MALT lymphoma to H pylori eradication therapy and is closely associated with the presence of chromosomal abnormalities. Trisomy 3 may predict the aggressive development of MALT lymphoma.
文摘目的:探讨分析无创产前筛查(noninvasive prenatal screening,NIPS)技术在罕见常染色体三体(rare autosomal trisomies,RAT)及染色体拷贝数变异(copy number variation,CNV)筛查中的临床意义。方法:回顾性分析于2017年3月—2023年7月因NIPS提示RAT和(或)CNV高风险在泉州市妇幼保健院·儿童医院产前诊断中心行羊水染色体核型分析及单核苷酸多态性微阵列(single nucleotide polymorphism array,SNParray)检测的108例患者情况。结果:83例NIPS提示RAT高风险者中产前诊断结果异常共15例,阳性预测值为18.07%,分别为1例致病性拷贝数变异(pathogenic copy number variants,pCNV)、9例临床意义不明确(variants of uncertain significance,VOUS)、4例杂合性丢失(loss of heterozygosity,LOH)及1例VOUS+LOH。25例NIPS提示CNV高风险者中产前诊断结果异常共16例,阳性预测值为64.00%,分别为11例pCNV、1例可能致病性拷贝数变异(likely pathogenic copy number variants,lpCNV)及4例VOUS。结论:NIPS技术对于RAT高风险阳性预测值不高,但提示不良妊娠结局风险增加;对于CNV高风险筛查有一定的应用价值。当NIPS提示RAT和染色体CNV高风险,应结合产前诊断结果及超声随访对胎儿预后进行评估,并加强妊娠期监测和管理。
